Evidence map›Paper›PMID 34346033›Full record

ArticleJournal of nephrology2022

Efficacy of systematic coronavirus screening by PCR and viral cultures in addition to triage in limiting the spread of SARS-CoV-2 within a hemodialysis unit.

Mohamed Tayeb Salaouatchi, Bhavna Mahadeb, Philippe Clevenbergh, Evelyne Maillart, Maria Mesquita, Irina Nechita, Frederic Collart

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mohamed Tayeb SalaouatchiNephrology Department, University Hospital Brugmann, Brussels, Belgium. Mohamed.Salaouatchi@ulb.be.
Bhavna MahadebMicrobiology Department, Laboratoire Hospitalier Universitaire de Bruxelles - Universitairy Laboratorium Brussel (LHUB-ULB); Infection Control Unit, University Hospital Brugmann, Brussels, Belgium.
Philippe ClevenberghInfectious Diseases Clinic, University Hospital Brugmann, Brussels, Belgium.
Evelyne MaillartInfectious Diseases Clinic, University Hospital Brugmann, Brussels, Belgium.
Maria MesquitaNephrology Department, University Hospital Brugmann, Brussels, Belgium.
Irina NechitaNephrology Department, University Hospital Brugmann, Brussels, Belgium.
Frederic CollartNephrology Department, University Hospital Brugmann, Brussels, Belgium.
Centre Hospitalier Universitaire Brugmann · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with end-stage-renal-disease (ESRD) undergoing hemodialysis (HD) represent a vulnerable population for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, due to their intrinsic fragility and increased exposure to the virus. Therefore, applying effective screening strategies and infection control measures is essential to control the spread of the epidemic within hemodialysis centers.

objectiveDescription and evaluation of the efficacy of systematic screening by rt-PCR and viral cultures, in addition to triage to limit the spread of the epidemic. Evaluation of the performance of these tests using "post-hoc" SARS-CoV-2 serology as a surrogate marker of infection.

methodsOne hundred and forty-four patients undergoing hemodialysis in the Nephrology-Hemodialysis center of CHU Brugmann, Brussels, benefited from systematic virological screening using viral cultures in asymptomatic patients, or molecular tests (rt-PCR) for symptomatic ones, in addition to general prevention measures. Post-hoc serology was performed in all patients.

resultsThirty-eight (26.3%) individuals were infected with SARS-CoV-2. Seventeen infected patients (44.7%) were asymptomatic and thus detected by viral culture. Our strategy allowed us to detect and isolate 97.4% of the infected patients, as proven by post-hoc serology. Only one patient, missed by clinical screening and sequential viral cultures, had a positive serology.

conclusionThe implementation of a control and prevention strategy based on a systematic clinical and virological screening showed its effectiveness in limiting (and shortening) the spread of the SARS-CoV-2 epidemic within our hemodialysis unit.

Indexed as

COVID-19SARS-CoV-2Hemodialysis Units, HospitalHumansPolymerase Chain ReactionRenal DialysisTriageChronic hemodialysisControl and preventionSARS-CoV-2ScreeningViral culture

Identifiers

PMID34346033
PMCPMC8330470
OpenAlexW3189796377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.